Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/04/2012US8258152 N-substituted azaindoles and methods of use
09/04/2012US8258151 3-aminoimidazo [1,2-A] pyridine derivatives as SGLT inhibitors
09/04/2012US8258150 Treatment of inflammatory diseases
09/04/2012US8258149 Isoquinoline derivatives
09/04/2012US8258148 Spiroindoline modulators of muscarinic receptors
09/04/2012US8258147 Compositions and methods for treating and preventing dermatoses
09/04/2012US8258146 Minoxidil aqueous composition containing bile acid
09/04/2012US8258145 Method of treating brain cancer
09/04/2012US8258144 Inhibitors of protein kinases
09/04/2012US8258143 Methods of using substituted pyrrolo[2,3-d]pyrimidines for targeting tumor cells and treating cancer
09/04/2012US8258142 Substituted 8-[6-amino-3-pyridyl]xanthines
09/04/2012US8258141 Organic compounds
09/04/2012US8258140 Chemical compounds—643
09/04/2012US8258139 Method of treatment for mental disorders
09/04/2012US8258138 Potassium channel blockers
09/04/2012US8258137 Process for release of biologically active species from mesoporous oxide systems
09/04/2012US8258136 Pyridazine compound and use thereof
09/04/2012US8258135 Quinolizidinone M1 receptor positive allosteric modulators
09/04/2012US8258134 Pyridazinone glucokinase activators
09/04/2012US8258133 2-amino-bicyclo[3.1.0]hexane-2, 6-dicarboxylic ester derivative
09/04/2012US8258132 Pharmaceutical composition of a tachykinin receptor antagonist
09/04/2012US8258131 Fused bicyclic compound
09/04/2012US8258130 Pyrimidine hydrazide compounds as PGDS inhibitors
09/04/2012US8258129 4-heterocycloalkylpyri(mi)dines, process for the preparation thereof and their use as medicaments
09/04/2012US8258128 Organic compounds
09/04/2012US8258127 Methods for treating latent tuberculosis
09/04/2012US8258126 Vitamin D3 analogues for the prevention and treatment of bone disorders
09/04/2012US8258125 HDL-boosting combination therapy complexes
09/04/2012US8258124 Combination medicament
09/04/2012US8258123 C-19 steroids for cosmetic and further uses
09/04/2012US8258122 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
09/04/2012US8258121 Glyceryl and glycol acid compounds
09/04/2012US8258120 9-substituted minocycline compounds
09/04/2012US8258119 Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
09/04/2012US8258118 4-pyridinone compounds and their use for cancer
09/04/2012US8258117 Composition and method for the repair and regeneration of cartilage and other tissues
09/04/2012US8258116 Combination therapy for the treatment of HCV infection
09/04/2012US8258115 Stable salts of S-adenosylmethionine and process for the preparation thereof
09/04/2012US8258114 Modulation of glucose-6-phosphatase translocase expression
09/04/2012US8258106 Immunostimulatory nucleic acid molecules
09/04/2012US8258105 Antisense oligonucleotides optimized for kidney targeting
09/04/2012US8258104 Method and composition for treating allergic diseases
09/04/2012US8258103 Pesticidal composition
09/04/2012US8258097 Amino acid derivatives
09/04/2012US8257931 Regulation of protein synthesis
09/04/2012US8257780 Therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders and methods of using
09/04/2012US8257755 Metabolic syndrome-improving agent and medicine, supplement, functional food and food additive containing the same
09/04/2012US8257754 Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
09/04/2012US8257745 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
09/04/2012US8257741 Solid pharmaceutical dispersions with enhanced bioavailability
09/04/2012US8257733 Methods and compositions for treating proliferative diseases
09/04/2012US8257730 Steroid-containing sustained release intraocular implants and related methods
09/04/2012US8257726 Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices
09/04/2012US8257693 Composition for maintaining healthy kidney function
09/04/2012US8257692 Polypeptide having an improved cytosine deaminase activity
09/04/2012US8257691 Composition and dosage form comprising a particle formulation and suspending vehicle
09/04/2012US8257690 Protein-based polymer tissue adhesives for medical use
09/04/2012US8257686 Compositions and methods relating to prevention of chemotherapy-induced alopecia
09/04/2012US8257683 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
09/04/2012US8257478 Use of marine fungus originated compounds as antifouling agents
09/04/2012CA2737025C Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
09/04/2012CA2703697C Acid addition salts of hydropyridine derivatives
09/04/2012CA2700679C Novel crystal form of 5-hydroxy-1-methylhydantoin
09/04/2012CA2676443C Atorvastatin calcium propylene glycol solvates
09/04/2012CA2656578C Tyrosine kinase inhibitors
09/04/2012CA2621365C Compositions and methods for the sustained release of beta-alanine
09/04/2012CA2587074C 4-hydroxybenzomorphans
09/04/2012CA2556373C Prevention, treatment, and amelioration of radiation induced enteritis
09/04/2012CA2554797C 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-one derivatives as pde4 inhibitors
09/04/2012CA2544632C Enos transcription enhancers for use in the cell therapy of ischemic heart diseases
09/04/2012CA2543865C Compositions comprising cyclohexylamines and aminoadamantanes
09/04/2012CA2528848C Thienopyrimidine derivatives as potassium channel inhibitors
09/04/2012CA2524271C Controlled release bioactive agent delivery device
09/04/2012CA2513276C Compositions containing coenzyme q10
09/04/2012CA2507429C Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
09/04/2012CA2506716C Carboxamides
09/04/2012CA2501819C Imidazole derivative and their use as peripherally-selective inhibitors of dopa nine-beta-hydroxylase
09/04/2012CA2471812C Targeted retrograde gene delivery to motor neurons
09/04/2012CA2448745C Compositions based on amino acids for improving the myocardial ventricular function in patients suffering from diabetes
09/04/2012CA2432971C Polypeptides
09/04/2012CA2318374C Human suppressor trna oligonucleotides and methods of use for same
09/03/2012CA2734014A1 Cold sore formulation and related method of manufacture
08/2012
08/30/2012WO2012116288A1 2-amino-naphthyridine derivatives
08/30/2012WO2012116282A2 Protein nanocarriers for topical delivery
08/30/2012WO2012116279A1 Cannabinoid receptor modulators
08/30/2012WO2012116278A1 Cannabinoid receptor modulators
08/30/2012WO2012116277A1 Cannabinoid receptor modulators
08/30/2012WO2012116276A1 Crystalline forms and processes for the preparation of condensed azacycles ( cannabinoid receptor modulators)
08/30/2012WO2012116272A2 Polymer conjugated protein micelles
08/30/2012WO2012116257A1 Anti-viral compounds
08/30/2012WO2012116254A2 Chrysophaentin analogs that inhibit ftsz protein
08/30/2012WO2012116247A1 Hsp90 inhibitory compounds in treating jak/stat signaling-mediated cancers
08/30/2012WO2012116246A2 Pesticidal compostions and processes related thereto
08/30/2012WO2012116238A1 PHARMACEUTICAL FORMULATIONS OF ACETYL-11-KETO-β-BOSWELLIC ACID, DIINDOLYLMETHANE, AND CURCUMIN FOR PHARMACEUTICAL APPLICATIONS
08/30/2012WO2012116237A2 Heterocyclic compounds and uses thereof
08/30/2012WO2012116196A2 Substituted lactosyl compounds and use thereof for cellular imaging and therapy
08/30/2012WO2012116176A2 Asymmetric ureas and medical uses thereof
08/30/2012WO2012116170A1 Inhibitors of bromodomains as modulators of gene expression
08/30/2012WO2012116151A2 Substituted aromatic sulfur compounds and methods of their use
08/30/2012WO2012116128A1 Use of teriflunomide for treating cognitive impairment
1 ... 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 ... 7860